OnKure Therapeutics OKUR
NASDAQ OKUR
$2.53 -0.05 (-1.94%)
As of: Oct 23, 2026 · 3:52 PM EDT

OnKure Therapeutics (OKUR) Price to Sales (2025 - 2026)

Updated

Analysis

OnKure Therapeutics (OKUR) Price to Sales (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.26 Bn 1,101.85 Bn 19.71 Bn
2 Johnson & Johnson 635.92 Bn 555.78 Bn 17.30 Bn
3 AbbVie 506.32 Bn 479.44 Bn 12.70 Bn
4 Merck 358.38 Bn 312.76 Bn 12.21 Bn
5 Novartis Ag 293.00 Bn 256.99 Bn 11.24 Bn
6 Astrazeneca 265.76 Bn 239.44 Bn 12.86 Bn
7 Amgen 237.88 Bn 193.27 Bn 7.24 Bn
8 Gilead Sciences 195.26 Bn 169.45 Bn 6.22 Bn
9 Pfizer 171.34 Bn 117.99 Bn 10.94 Bn
10 OnKure Therapeutics 126.17 Mn -371.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 53.76
Mar 31, 2026 20.10
Dec 31, 2025 11.55
Sep 30, 2025 8.81
Jun 30, 2025 9.69
Mar 31, 2025 22.50
API Access

OnKure Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=OKUR&period=max&api_key=YOUR_API_KEY